mTOR inhibition abrogates human mammary stem cells and early breast cancer progression markers.
| Publicado en: | Breast Cancer Research Vol. 25; no. 1; pp. 1 - 18 |
|---|---|
| Autores principales: | , , , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
BioMed Central
10/30/2023
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=173342415&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 173342415 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 14655411 8UYJ jtl: Breast Cancer Research issn: 14655411 maglogo: N pubinfo: dt: 10/30/2023 vid: 25 iid: 1 pid: 24147 pub: BioMed Central artinfo: ui: 173342415 10.1186/s13058-023-01727-z 173342415 ppf: 1 ppct: 17 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: mTOR inhibition abrogates human mammary stem cells and early breast cancer progression markers. aug: au: Bouamar, Hakim Broome, Larry Esteban Lathrop, Kate Ida Jatoi, Ismail Brenner, Andrew Jacob Nazarullah, Alia Gorena, Karla Moncada Garcia, Michael Chen, Yidong Kaklamani, Virginia Sun, Lu-Zhe affil: Department of Cell Systems and Anatomy, School of Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|